कृपया अन्य खोज का प्रयास करें
Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Jason P. Rhodes | 52 | 2017 | Independent Chairman |
Jeffrey Statland | - | 2020 | Member of Scientific Advisory Board |
Catherine Stehman-Breen | 61 | 2019 | Independent Director |
Dirk Kersten | 49 | 2018 | Independent Director |
Edward M. Hurwitz | 61 | 2018 | Independent Director |
Louis M. Kunkel | - | - | Member of Scientific Advisory Board |
Charles Thornton | - | - | Member of Scientific Advisory Board |
Carlo Incerti | 65 | 2022 | Independent Director |
David C. Lubner | 60 | 2020 | Independent Director |
Sudhir Agrawal | 70 | - | Member of Scientific Advisory Board |
Nancy C. Andrews | 66 | - | Member of Scientific Advisory Board |
Francesco Muntoni | - | 2020 | Member of Scientific Advisory Board |
John G. Cox | 61 | 2024 | CEO, President & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है